Stay updated on Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page.

Latest updates to the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 is now displayed on the page history, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision indicator updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the version history list.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.2 was added to the history. The government funding status notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check82 days agoChange DetectedA site-wide funding notice was added and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedUI enhancements to the Record History page include a glossary toggle, color-coded highlights for changes (green for additions, red for deletions), and a new revision label: Revision: v3.4.0. A capitalization change is shown for the No FEAR Act Data item.SummaryDifference0.2%

Stay in the know with updates to Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page.